• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. ARTEGRAFT; COLLAGEN VASCULAR GRAFT Back to Search Results
Model Number AG715
Device Problems Material Puncture/Hole (1504); Material Integrity Problem (2978); Insufficient Information (3190)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/16/2023
Event Type  malfunction  
Event Description
There was a hole in the graft.
 
Manufacturer Narrative
The graft involved was not received for evaluation so the issue was not able to be confirmed.Additional patient information was requested on (b)(6) 2023 with no updates received as of (b)(6) 2023.Additional request for information was submitted on (b)(6) 2023 to clarify the series of events.No new information was provided to date.A review of complaint data within the past three years was completed and there were no indications or trends identified that would suggest an increase in holes in grafts that have been fully processed.As 100% of the grafts are pressure tested and visually inspected prior to release, we remain inconclusive about the root cause of the issue.Based on the documentation and complaint history review, we do not believe there is a systemic issue with these devices.No further actions were determined to be necessary at this time; all product quality and clinical issues will continue to be monitored within quality assurance trending.
 
Event Description
The graft was not used and did not come in contact with the patient.The product was stored in their sterile core at operating room normal temperatures.The product was removed from packaging and flushed per ifu packaging.There was no unusual smell, but there was a slit in the graft.
 
Manufacturer Narrative
Follow-up report 1.Additional information was received: sections b5, d9, h6 were updated.Actual complaint product lot 21k284-055 was returned and evaluation was conducted.Product code and length were verified.The graft was visually inspected by both quality personnel and a manufacturing technician for any signs of abnormality.The inspections did not identify any evidence of a hole or slit in the graft; no issues were identified with the returned product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEGRAFT
Type of Device
COLLAGEN VASCULAR GRAFT
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
206 north center drive
north brunswick NJ 08902 4247
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
206 north center drive
north brunswick 08902
Manufacturer Contact
monte nelson
206 north center drive
north brunswick, NJ 08902-4247
7324228333
MDR Report Key18119795
MDR Text Key327931172
Report Number2247686-2023-00008
Device Sequence Number1
Product Code LXA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N16837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAG715
Device Catalogue NumberN/A
Device Lot Number21K284-055
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-